Continuation of term of appointment of following Directors subject to shareholder approval at the AGM: 1. Mr. Girishkumar Shah (DIN: 00469291) 2. Mr. Sanjay Marathe (DIN: 01316388) 3. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemcrux Enterprises' board, meeting on 6 August 2025 at Vadodara, approved the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended 30 June 2025). The board accepted the resignation of Chief Financial Officer Mr. Ramesh Kambariya, effective end of business hours on 11 August 2025, to pursue a career opportunity aligned with his personal goals. A new employee stock option scheme, ESOP 2025, covering 20,00,000 equity shares of Rs. 10 each was cleared for eligible employees, subject to shareholder approval. The authorised share capital was proposed to be raised from Rs. 15 crore to Rs. 20 crore, alongside amendments to the MoA. The continuation of three directors — Executive Chairman Girishkumar Shah and Managing Director Sanjay Marathe (both promoter-directors) beyond age 70, and Independent Director Bhanubhai Patel beyond age 75 — was recommended for shareholder approval. KSPS & Co. LLP was recommended as the new secretarial auditor for a five-year term starting FY26.
The abrupt CFO exit introduces near-term uncertainty around finance and reporting continuity, and the new ESOP plus capital expansion signal potential future dilution and fundraising plans. Investors should track the Q1 numbers closely and watch for a new CFO appointment announcement.